344 related articles for article (PubMed ID: 18477018)
1. Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis.
Delclaux C; Malinvaud D; Chevalier-Bidaud B; Callens E; Mahut B; Bonfils P
Clin Exp Allergy; 2008 Jul; 38(7):1140-7. PubMed ID: 18477018
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis.
Mahut B; Plantier L; Malinvaud D; Chevalier-Bidaud B; Bonfils P; Delclaux C
Respir Med; 2012 Jan; 106(1):68-74. PubMed ID: 21855311
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of nasal and exhaled nitric oxide concentration in nasal polyposis].
Gilain L; Bedu M; Jouaville L; Guichard C; Advenier D; Mom T; Laurent S; Caillaud D
Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):234-42. PubMed ID: 12410120
[TBL] [Abstract][Full Text] [Related]
4. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
Pedroletti C; Lundahl J; Alving K; Hedlin G
Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
[TBL] [Abstract][Full Text] [Related]
5. Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?
Williamson PA; Vaidyanathan S; Clearie K; Barnes M; Lipworth BJ
Clin Exp Allergy; 2011 Oct; 41(10):1379-85. PubMed ID: 21676042
[TBL] [Abstract][Full Text] [Related]
6. Impairment of nitric oxide output of conducting airways in primary ciliary dyskinesia.
Mahut B; Escudier E; de Blic J; Zerah-Lancner F; Coste A; Harf A; Delclaux C
Pediatr Pulmonol; 2006 Feb; 41(2):158-63. PubMed ID: 16353174
[TBL] [Abstract][Full Text] [Related]
7. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease.
Williamson PA; Vaidyanathan S; Clearie K; Stewart M; Lipworth BJ
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):162-7. PubMed ID: 20674828
[TBL] [Abstract][Full Text] [Related]
8. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.
Marcucci F; Passalacqua G; Canonica GW; Frati F; Salvatori S; Di cara G; Petrini I; Bernini M; Novembre E; Bernardini R; Incorvaia C; Sensi LG
Respir Med; 2007 Jul; 101(7):1600-8. PubMed ID: 17482451
[TBL] [Abstract][Full Text] [Related]
9. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis.
Ehnhage A; Olsson P; Kölbeck KG; Skedinger M; Dahlén B; Alenius M; Stjärne P;
Allergy; 2009 May; 64(5):762-9. PubMed ID: 19191775
[TBL] [Abstract][Full Text] [Related]
10. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
[TBL] [Abstract][Full Text] [Related]
11. Influence of allergy on the symptoms and treatment of nasal polyposis.
Bonfils P; Avan P; Malinvaud D
Acta Otolaryngol; 2006 Aug; 126(8):839-44. PubMed ID: 16846927
[TBL] [Abstract][Full Text] [Related]
12. Exhaled nitric oxide measurement in patients affected by nasal polyposis.
Galli J; Montuschi P; Passàli GC; Laruffa M; Parrilla C; Paludetti G
Otolaryngol Head Neck Surg; 2012 Aug; 147(2):351-6. PubMed ID: 22470156
[TBL] [Abstract][Full Text] [Related]
13. Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis.
Makinen T; Lehtimäki L; Kinnunen H; Nieminen R; Kankaanranta H; Moilanen E
Int Arch Allergy Immunol; 2009; 148(2):154-60. PubMed ID: 18802360
[TBL] [Abstract][Full Text] [Related]
14. Effect of systemic steroids on humming nasal nitric oxide in chronic rhinosinusitis with nasal polyposis.
Vaidyanathan S; Williamson P; Anderson K; Lipworth B
Ann Allergy Asthma Immunol; 2010 Dec; 105(6):412-7. PubMed ID: 21130377
[TBL] [Abstract][Full Text] [Related]
15. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.
Mascia K; Haselkorn T; Deniz YM; Miller DP; Bleecker ER; Borish L;
J Allergy Clin Immunol; 2005 Nov; 116(5):970-5. PubMed ID: 16275362
[TBL] [Abstract][Full Text] [Related]
16. Comment on: Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis. Delclaux C, et al.
Vaidyanathan S; Williamson P; Lipworth BJ
Clin Exp Allergy; 2008 Oct; 38(10):1697. PubMed ID: 18727620
[No Abstract] [Full Text] [Related]
17. Peripheral inflammation in patients with asthmatic symptoms but normal lung function.
Lehtimäki L; Kankaanranta H; Saarelainen S; Turjanmaa V; Moilanen E
J Asthma; 2005 Sep; 42(7):605-9. PubMed ID: 16169798
[TBL] [Abstract][Full Text] [Related]
18. Is nasal polyposis a determinant of bronchial hyperresponsiveness and altered quality of life in asthmatic subjects? A case-control study.
Riccioni G; Bucciarelli T; Di Ilio C; Corradi F; Vecchia RD; Staniscia T; Mattei PA; D'Orazio N
Ann Clin Lab Sci; 2006; 36(2):170-3. PubMed ID: 16682513
[TBL] [Abstract][Full Text] [Related]
19. [Physiology and physiopathology of the distal airways in asthma].
Álvarez Puebla MJ; García Río F
Arch Bronconeumol; 2011 Apr; 47 Suppl 2():10-6. PubMed ID: 21640279
[TBL] [Abstract][Full Text] [Related]
20. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis.
Small CB; Stryszak P; Danzig M; Damiano A
J Allergy Clin Immunol; 2008 Apr; 121(4):928-32. PubMed ID: 18234321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
